These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 36255451)

  • 41. Proteomics analysis of blood plasma in HIV-infected patients with chronic kidney disease.
    Lavinya AA; Lee CS; Hashim OH; Azwa I; Rajasuriar R; Lim SK; Wong YF
    Clin Biochem; 2019 Nov; 73():90-97. PubMed ID: 31401122
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chronic kidney disease as a coronary artery disease risk equivalent.
    Briasoulis A; Bakris GL
    Curr Cardiol Rep; 2013 Mar; 15(3):340. PubMed ID: 23338722
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Coronary Artery Bypass Grafting in Patients with Chronic Kidney Disease: Chronic Kidney Disease Has an Independent Adverse Effect on the Long-Term Outcome of Coronary Artery Bypass Grafting.
    Endo D; Yamamoto T; Kajimoto K; Matsushita S; Dohi S; Shimada A; Yokoyama Y; Io H; Suzuki Y; Tabata M; Amano A
    Biomed Res Int; 2022; 2022():4994970. PubMed ID: 35528157
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human Kidney Tubule-Specific Gene Expression Based Dissection of Chronic Kidney Disease Traits.
    Beckerman P; Qiu C; Park J; Ledo N; Ko YA; Park AD; Han SY; Choi P; Palmer M; Susztak K
    EBioMedicine; 2017 Oct; 24():267-276. PubMed ID: 28970079
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Extracellular Fluid Excess Is Significantly Associated With Coronary Artery Calcification in Patients With Chronic Kidney Disease.
    Park S; Lee CJ; Jhee JH; Yun HR; Kim H; Jung SY; Kee YK; Yoon CY; Park JT; Kim HC; Han SH; Kang SW; Park S; Yoo TH
    J Am Heart Assoc; 2018 Jun; 7(13):. PubMed ID: 29960990
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Saphenous vein aorto-coronary graft atherosclerosis in patients with chronic kidney disease: more plaque calcification and necrosis, but less vasoconstrictor potential.
    Baars T; Kleinbongard P; Böse D; Konorza T; Möhlenkamp S; Hippler J; Erbel R; Heusch G
    Basic Res Cardiol; 2012 Nov; 107(6):303. PubMed ID: 23052640
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The association between plasma proteomics and incident cardiovascular disease identifies MMP-12 as a promising cardiovascular risk marker in patients with chronic kidney disease.
    Feldreich T; Nowak C; Carlsson AC; Östgren CJ; Nyström FH; Sundström J; Carrero-Roig JJ; Leppert J; Hedberg P; Giedraitis V; Lind L; Cordeiro A; Ärnlöv J
    Atherosclerosis; 2020 Aug; 307():11-15. PubMed ID: 32702535
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nonculprit coronary plaque characteristics of chronic kidney disease.
    Kato K; Yonetsu T; Jia H; Abtahian F; Vergallo R; Hu S; Tian J; Kim SJ; Lee H; McNulty I; Lee S; Uemura S; Jang Y; Park SJ; Mizuno K; Yu B; Jang IK
    Circ Cardiovasc Imaging; 2013 May; 6(3):448-56. PubMed ID: 23536265
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relation between mild to moderate chronic kidney disease and coronary artery disease determined with coronary CT angiography.
    Joosen IA; Schiphof F; Versteylen MO; Laufer EM; Winkens MH; Nelemans PJ; Kooman JP; Hofstra L; Wildberger JE; Leiner T
    PLoS One; 2012; 7(10):e47267. PubMed ID: 23071773
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endothelial Microparticles and Systemic Complement Activation in Patients With Chronic Kidney Disease.
    Jalal D; Renner B; Laskowski J; Stites E; Cooper J; Valente K; You Z; Perrenoud L; Le Quintrec M; Muhamed I; Christians U; Klawitter J; Lindorfer MA; Taylor RP; Holers VM; Thurman JM
    J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 30006493
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chronic kidney disease-related atherosclerosis - proteomic studies of blood plasma.
    Luczak M; Formanowicz D; Pawliczak E; Wanic-Kossowska M; Wykretowicz A; Figlerowicz M
    Proteome Sci; 2011 May; 9():25. PubMed ID: 21569504
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lipoprotein (a) and the Risk of Chronic Kidney Disease in Hospitalized Japanese Patients.
    Tada H; Yamagami K; Nishikawa T; Yoshida T; Teramoto R; Sakata K; Takamura M; Kawashiri MA
    Intern Med; 2020; 59(14):1705-1710. PubMed ID: 32669515
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Heart Disease and the Kidneys.
    Silva RP; Diógenes C
    Contrib Nephrol; 2021; 199():71-79. PubMed ID: 34428764
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In-situ analysis of mast cells and dendritic cells in coronary atherosclerosis in chronic kidney disease (CKD).
    Wachter DL; Neureiter D; Câmpean V; Hilgers KF; Büttner-Herold M; Daniel C; Benz K; Amann K
    Histol Histopathol; 2018 Aug; 33(8):871-886. PubMed ID: 29616745
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dietary Protein Sources and Risk for Incident Chronic Kidney Disease: Results From the Atherosclerosis Risk in Communities (ARIC) Study.
    Haring B; Selvin E; Liang M; Coresh J; Grams ME; Petruski-Ivleva N; Steffen LM; Rebholz CM
    J Ren Nutr; 2017 Jul; 27(4):233-242. PubMed ID: 28065493
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Associations among serum trimethylamine-N-oxide (TMAO) levels, kidney function and infarcted coronary artery number in patients undergoing cardiovascular surgery: a cross-sectional study.
    Mafune A; Iwamoto T; Tsutsumi Y; Nakashima A; Yamamoto I; Yokoyama K; Yokoo T; Urashima M
    Clin Exp Nephrol; 2016 Oct; 20(5):731-739. PubMed ID: 26676906
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Matrix Metalloproteinase 2 and Osteoprotegrin as New Markers of Increased Atherosclerotic Risk in Egyptian Patients with Chronic Kidney Disease.
    Elsaeed AM; Ibrahiem AH; Ali AA
    Egypt J Immunol; 2017 Jan; 24(1):153-164. PubMed ID: 29120587
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
    Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regional distribution and severity of arterial calcification in patients with chronic kidney disease stages 1-5: a cross-sectional study of the Copenhagen chronic kidney disease cohort.
    Sørensen IMH; Saurbrey SAK; Hjortkjær HØ; Brainin P; Carlson N; Ballegaard ELF; Kamper AL; Christoffersen C; Feldt-Rasmussen B; Kofoed KF; Bro S
    BMC Nephrol; 2020 Dec; 21(1):534. PubMed ID: 33297991
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chronic kidney disease and coronary atherosclerosis: evidences from intravascular imaging.
    Iwai T; Kataoka Y; Otsuka F; Asaumi Y; Nicholls SJ; Noguchi T; Yasuda S
    Expert Rev Cardiovasc Ther; 2019 Oct; 17(10):707-716. PubMed ID: 31592685
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.